Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bricker

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Frontiers in Immunology|June 20, 2022
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19Lyn R Frumkin, Michaela Lucas, Curtis L Scribner, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesisJuhee Son, Shimeng Huang, Qiru Zeng, et al.
Mbio|January 18, 2022
JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus PathogenesisJuhee Son, Shimeng Huang, Qiru Zeng, et al.
Immunity|August 31, 2021
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Frontiers in Immunology|June 20, 2022
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19Lyn R Frumkin, Michaela Lucas, Curtis L Scribner, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesisJuhee Son, Shimeng Huang, Qiru Zeng, et al.
Mbio|January 18, 2022
JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus PathogenesisJuhee Son, Shimeng Huang, Qiru Zeng, et al.
Immunity|August 31, 2021
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Nature|June 21, 2021
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsRita E Chen, Emma S Winkler, James Brett Case, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Pageof 13